GARNET: High SVR Rates Following Eight-Week Treatment with Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir for Patients with HCV Genotype 1b Infection: 888
暂无分享,去创建一个
T. Asselah | X. Forns | T. Pilot‐Matias | S. Zeuzem | D. Shaw | J. Feld | D. Cohen | R. Hazzan | T. Welzel | E. Dumas | Wenjing Lu